Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of sunitinib in non-small cell lung cancer with brain metastases
2006-004451-38Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in non-small cell lung cancer (NSCLC), sponsored by Pfizer. Primary endpoint: Progression-free survival. Started Apr 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-004451-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004451-38.